Response to tozinameran (BNT162b2) booster in twice-vaccinated kidney transplant and maintenance dialysis patients
Author:
Funder
Ministry of Health, State of Israel
Publisher
Springer Science and Business Media LLC
Subject
Nephrology
Link
https://link.springer.com/content/pdf/10.1007/s40620-021-01235-3.pdf
Reference5 articles.
1. @US_FDA (2021) FDA authorizes booster dose of Pfizer-BioNTech COVID-19 vaccine for certain populations. FDA. Wed, 09/22/2021–19/27/2021
2. Hou Y, Lu K, Kuo K (2021) The efficacy of COVID-19 vaccines in chronic kidney disease and kidney transplantation patients: a narrative review. Vaccines 9(8):885. https://doi.org/10.3390/vaccines9080885
3. Ben-Dov IZ, Oster Y, Tzukert K et al (2021) Impact of tozinameran (BNT162b2) mRNA vaccine on kidney transplant and chronic dialysis patients: 3–5 months followup. J Nephrol https://doi.org/10.1101/2021.06.12.21258813
4. Werbel W, Boyarsky B, Ou M et al (2021) Safety and immunogenicity of a third dose of SARS-CoV-2 vaccine in solid organ transplant recipients: a case series. Ann Intern Med 174(9):1330. https://doi.org/10.7326/L21-0282
5. Yahav D, Rozen-Zvi B, Mashraki T et al (2021) Immunosuppression reduction when administering a booster dose of the BNT162b2 mRNA SARS-CoV-2 vaccine in kidney transplant recipients without adequate humoral response following two vaccine doses: protocol for a randomised controlled trial (BECAME study). BMJ Open 11(10):e055611. https://doi.org/10.1136/bmjopen-2021-055611
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Humoral immunity trends in a hemodialysis cohort following SARS‐CoV‐2 mRNA booster: A cohort study;Health Science Reports;2024-02
2. Effectiveness, Immunogenicity and Harms of Additional SARS-CoV-2 Vaccine Doses in Kidney Transplant Recipients: A Systematic Review;Vaccines;2023-04-18
3. Trajectory of Humoral Responses to Two Doses of ChAdOx1 nCoV-19 Vaccination in Patients Receiving Maintenance Hemodialysis;Microbiology Spectrum;2023-04-13
4. Immunogenicity of COVID-19 vaccines in solid organ transplant recipients: a systematic review and meta-analysis;Clinical Microbiology and Infection;2023-04
5. Humoral and cellular response after BNT162b2 vaccine booster in hemodialysis patients and kidney transplant recipients;Clinical and Experimental Nephrology;2023-02-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3